v3.26.1
CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS’ EQUITY - USD ($)
$ in Thousands
Total
Common Stock
Additional Paid-In Capital
Accumulated Other Comprehensive Income (Loss)
Accumulated Deficit
Balance at beginning of period (in shares) at Feb. 01, 2025   565,719,239      
Balance at beginning of period at Feb. 01, 2025 $ 1,069,196 $ 35 $ 2,680,012 $ (846) $ (1,610,005)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Issuance of common stock from equity compensation plans (in shares)   3,616,711      
Issuance of common stock from equity compensation plans 22   22    
Stock-based compensation expense 78,958   78,958    
Other comprehensive (loss) income 1,519     1,519  
Net income (loss) (22,121)       (22,121)
Balance at end of period (in shares) at May. 03, 2025   569,335,950      
Balance at end of period at May. 03, 2025 1,127,574 $ 35 2,758,992 673 (1,632,126)
Balance at beginning of period (in shares) at Jan. 31, 2026   580,715,597      
Balance at beginning of period at Jan. 31, 2026 1,420,447 $ 36 3,035,176 4,357 (1,619,122)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Issuance of common stock from equity compensation plans (in shares)   3,042,276      
Issuance of common stock from equity compensation plans 11   11    
Shares withheld for net share settlement of equity awards (in shares)   (1,047,791)      
Shares withheld for net share settlement of equity awards (34,345)   (34,345)    
Stock-based compensation expense 79,997   79,997    
Other comprehensive (loss) income (3,028)     (3,028)  
Net income (loss) 44,508       44,508
Balance at end of period (in shares) at May. 02, 2026   582,710,082      
Balance at end of period at May. 02, 2026 $ 1,507,590 $ 36 $ 3,080,839 $ 1,329 $ (1,574,614)